A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 27
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : DAIDS
Long Form : Division of AIDS
No. Year Title Co-occurring Abbreviation
1  2021 Improving retention of community-recruited participants in HIV prevention research through Saturday household visits; findings from the HPTN 071 (PopART) study in South Africa. ANOVA, PC
2  2020 Determining hematological, biochemical and immunological reference values in healthy adults with high-risk for HIV acquisition in Mozambique. HIV, NIH
3  2019 Severe haematologic toxicity is rare in high risk HIV-exposed infants receiving combination neonatal prophylaxis. aOR, cART, CNP, Hb, NC, NP
4  2018 Similar HIV protection from four weeks of zidovudine versus nevirapine prophylaxis among formula-fed infants in Botswana. MTCT, NVP, ZDV
5  2018 Treatment for HIV-associated cryptococcal meningitis. AmBd, CI, FLU, IMSEAR, MD, RR, SUCRA, WHO ICTRP
6  2017 Laboratory Accuracy Improvement in the UK NEQAS Leucocyte Immunophenotyping Immune Monitoring Program: An Eleven-Year Review via Longitudinal Mixed Effects Modeling. EQA, IQA, UK NEQAS
7  2017 Multicenter study of skin rashes and hepatotoxicity in antiretroviral-naive HIV-positive patients receiving non-nucleoside reverse-transcriptase inhibitor plus nucleoside reverse-transcriptase inhibitors in Taiwan. aOR, cART, EFV, HCV, NNRTI, NRTIs, NVP, RPV
8  2016 Safety of zidovudine/lamivudine scored tablets in children with HIV infection in Europe and Thailand. AEs, AST, EPPICC, PY, WBC, ZDV
9  2015 Anemia and Red Blood Cell Abnormalities in HIV-Infected and HIV-Exposed Breastfed Infants: A Secondary Analysis of the Kisumu Breastfeeding Study. ARV, KiBS, PMTCT
10  2015 Establishment of biochemistry reference values for healthy Tanzanian infants, children and adolescents in Kilimanjaro Region. NIH
11  2015 Safety of darunavir and atazanavir in HIV-infected children in Europe and Thailand. AE, ALT, ART, ATV, DRV, PY
12  2014 Normal laboratory reference intervals among healthy adults screened for a HIV pre-exposure prophylaxis clinical trial in Botswana. BUN, TDF/FTC
13  2014 Reference values for clinical laboratory parameters in young adults in Maputo, Mozambique. ---
14  2013 Incidence and predictors of severe anemia in Asian HIV-infected children using first-line antiretroviral therapy. HAART, WHO
15  2011 Length and complexity of US and international HIV consent forms from federal HIV network trials. NIH
16  2011 Population-based biochemistry, immunologic and hematological reference values for adolescents and young adults in a rural population in Western Kenya. Hb, Hct, MCV, RBC
17  2011 The NIAID Division of AIDS enterprise information system: integrated decision support for global clinical research programs. NIAID
18  2011 Workshop summary: Novel biomarkers for HIV incidence assay development. HIV, NIAID, NIH
19  2010 Beyond 2010: Gaps, Challenges, and Priorities for the Future of Preclinical HIV Preexposure Prophylaxis (PrEP): Summary of the October 20-21, 2009 Workshop. NIAID, NIH, PD, PK, PrEP
20  2010 Establishment of haematological and immunological reference values for healthy Tanzanian children in Kilimanjaro Region. Hb, Hct
21  2010 Implications of HIV PrEP trials results. BMGF, CDC, FDA, NIAID, NIH, PrEP, PrEP, TDF, USAID
22  2009 CLSI-derived hematology and biochemistry reference intervals for healthy adults in eastern and southern Africa. AEs
23  2009 Hepatic profile analyses of tipranavir in Phase II and III clinical trials. HR, KM, SAE, TEs
24  2008 Summary of presentations at the NIH/NIAID New Humanized Rodent Models 2007 Workshop. NIAID
25  2006 Range of normal neutrophil counts in healthy zimbabwean infants: implications for monitoring antiretroviral drug toxicity. ANCs
26  1994 HIV-mediated defects in immune regulation. NIAID
27  1994 Mechanisms of HIV/SIV mucosal transmission. NIAID